Glyceraldehyde phosphate and methyl esters of succinic acid. Two "new" potent insulin secretagogues.
We discovered that two physiologically occurring metabolic intermediates, glyceraldehyde phosphate and succinate, are potent insulin secretagogues. No other glycolytic intermediate besides glyceraldehyde phosphate was insulinotropic. Succinate, when added to islets as either its monomethyl or dimethyl ester to increase its cellular permeability, was also insulinotropic. In islets, as in other cell types, these esters are apparently hydrolyzed intracellularly to succinate. Unesterified succinate and other unesterified citric acid-cycle intermediates did not stimulate insulin release. Initiation of insulin release by esters of succinate suggests that mitochondrial metabolism alone is sufficient to initiate and support insulin release. However, this is specific for succinate in that esters of fumarate, pyruvate, and citrate were not insulinotropic.
MacDonald
M J
MJ
Department of Pediatrics, University of Wisconsin Medical School, Madison 53706.
Fahien
L A
LA
D000818:Animals; D002952:Citric Acid Cycle; D005985:Glyceraldehyde / Q000031:analogs & derivatives*; D005986:Glyceraldehyde 3-Phosphate / Q000494:pharmacology*; D006019:Glycolysis; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013386:Succinates / Q000494:pharmacology*
D007328:Insulin; D013386:Succinates; D005986:Glyceraldehyde 3-Phosphate; D005985:Glyceraldehyde; C056451:dimethyl succinate; C041105:monomethyl succinate